Offshoring and U.S. Biotech Labor Shortages
Every day we read about severe shortages of skilled biotech workers in the U.S.. At the same time, the trend to pharma offshoring and outsourcing is becoming more pronounced, and is moving from traditional pharma to biopharma.
We recently touched on some of these issues in Pharmaceutical Manufacturing. One question is whether today’s skills shortages reflect a lack of alignment between biotech training and industry requirements.
We would welcome any comments, critiques and responses from the biotech community.
Here is the article (which includes, on the last page, a very brief and informal poll)